Biochem Logo     

Current Event
03/5/10 "TBA"
by Dr. Robyn Maher ...more details

> Faculty Details

Paula Tracy, Ph.D.
Interim Chairperson and Professor
Paula.Tracy@uvm.edu
O: Given C401 L: Given C403
O: 802-656-1995 L: 802-656-1994

Research Interests:
Cancer Biology
Cardiovascular Biology & Disease
Signal Transduction & Cell Signaling

Background:
Dr. Tracy received her Ph.D. in Biology, with an emphasis in Biochemistry, at Syracuse University in 1977. Her current interests in how platelets regulate blood clotting reactions developed as a result of her 5 years of post doctoral training at the Mayo Clinic in Rochester, MN. Her first university appointment was made in 1983 as an Assistant Professor of Pathology at the University of Rochester, NY. She moved to the University of Vermont in 1985 as member of the Thrombosis Research Center. As a result of her research endeavors Dr. Tracy serves on the editorial board of several journals related to hemostasis and thrombosis, has been a member of the National Institutes of Health Hematology peer-review Hematology study section for eight years, served as Chairperson of the Gordon Conference on Hemostasis 1996, and is serving as the Program Chairperson (Basic Sciences) for the 22nd Annual Meeting of the International Society of Thrombosis & Haemostasis in Boston, MA, July 2009.

 

Project Description:

The principle objective of our laboratory is to develop a fundamental understanding of how platelets participate in and regulate the formation of the important bioregulatory effector molecule, thrombin. Thrombin generation is effected by a Ca2+-dependent, membrane-bound complex of the cofactor protein, factor Va, and the serine protease, factor Xa. One specific goal is to provide a quantitative understanding of the integrally related kinetic and binding events regulating the functional interactions of factors Va and Xa with the platelet membrane surface. The membrane receptors, the intracellular signalling pathways and the enzymatic processes controlling these events are being identified using biochemical and molecular biological approaches. A second major goal is to define how megakaryocytes, platelet progenitor cells, developmentally regulate the endocytosis and possible synthesis of the required cofactor factor V(a) and, to determine the cellular events regulating its endocytosis, its intracellular trafficking to storage granules and the phenotypic changes in the factor V molecule resulting from these interactions. Since the platelet-derived factor Va pool is essential for normal blood clotting, defining how platelets acquire this essential protein, process it and express it at their membrane surface is key in regulating thrombin generation. The formation of thrombin at the surface of platelets is pivotal to the physiological and pathophysiological functions they provide as they localize to vascular and extravascular tissue sites.



Student Opportunities:

Laboratory members become proficient in protein purification and several techniques used for protein characterization (SDS-PAGE, Western blotting, fluorography, autoradiography, amino acid analyses, HPLC, FPLC and MALDI-TOF mass spectrometry). Proficiency in the performance and analysis of chromogenic and fluoroscopic methods for assessing enzyme kinetic reactions can also be learned. Sterile technique is practiced as several cell lines are maintained in continuous culture. Platelets are isolated from whole blood donations on a daily basis. Platelet progenitor cells, megakaryocytes, are isolated from bone marrow aspirates as that primary mature cell population, or can be expanded and differentiated ex vivo from CD34+ bone marrow precursors. Other methods can include kinase assays, fluorescence-activated flow cytometric analyses, fluorescence-activated cell sorting, fluorescence microscopy and confocal microscopy.

 
Selected Publications:

Bouchard BA, Meisler NT, Nesheim ME, Liu C-X, Strickland DK and Tracy PB: A unique function for Low-density lipoprotein receptor related protein-1 (LRP-1): A component of a two-receptor system mediating specific endocytosis of plasma-derived factor V by megakaryocytes (2007). J Thromb Haemost. 6:638-644.

Bouchard BA, Williams JL, Meisler NT, Long MW, Tracy PB. (2005) Endocytosis of plasma-derived factor V by megakaryocytes occurs via a clathrin-dependent, specific membrane binding event. J Thromb Haemost. 3:541-51.

Gould WR, Simioni P, Silveira JR, Tormene D, Kalafatis M, Tracy PB. (2005) Megakaryocytes endocytose and subsequently modify human factor V in vivo to form the entire pool of a unique platelet-derived cofactor. J Thromb Haemost. 3:450-6.

Gould WR, Silveira JR, Tracy PB. (2004) Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor: characterization of purified platelet-derived factor V/Va J Biol Chem. 279(4):2383-93.

All Tracy publications